New Bristol-Myers drug improves survival in most common lung-cancer patients
May 29, 2015 at 15:30 PM EDT
Bristol-Myers Squibb Co.'s newest oncology drug improved survival in patients with the most common form of lung cancer, building the case for wider use of the medicine. In a study of 582 patients... To view the full story, click the title link.
